Ananda Pharma (AQSE:ANA) Asset Impairment Charge : £0.00 Mil (TTM As of Jul. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ananda Pharma Asset Impairment Charge?

Ananda Pharma's Asset Impairment Charge for the six months ended in Jul. 2024 was £0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jul. 2024 was £0.00 Mil.

Ananda Pharma Asset Impairment Charge Historical Data

The historical data trend for Ananda Pharma's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma Asset Impairment Charge Chart

Ananda Pharma Annual Data

Trend

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Asset Impairment Charge

Get a 7-Day Free Trial

Ananda Pharma Semi-Annual Data
	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jan24	Jul24
Asset Impairment Charge	Get a 7-Day Free Trial								-	-	-	-	-

Ananda Pharma Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jul. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

Ananda Pharma Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Ananda Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (AQSE:ANA) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.anandapharma.co.uk

Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.

Ananda Pharma Headlines

No Headlines